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Introduction
Sporotrichosis is a chronic granulomatous mycosis caused
by the dimorphic fungus Sporothrix schenckii, which is
widely distributed in nature and exists in a saprophytic
mycelial form on plant debris and soil. This disease is
caused by traumatic inoculation of the dimorphic fungus
S. schenckii [1]. In the past, infections were limited to the
cutaneous forms of the disease. Recently, occurrences of
more severe clinical forms of this mycosis have been
described, especially among immunocompromised indi-
viduals [2, 3].
The immunological mechanisms involved in the pre-
vention and control of sporotrichosis suggest that cell-
mediated immunity plays an important role in protecting
the host against S. schenckii [4]. In experimental infec-
tions, athymic nude mice are more susceptible to sporo-
trichosis, and acquired immunity against S. schenckii is
mainly mediated by T cell-activated macrophages [5, 6].
In contrast, the role of the humoral immune response
in protection against this fungus has not been studied in
detail. Although many studies have investigated antibody
responses in fungal infections, critical features, such as
fine antibody specificity or antibody isotype, have seldom
been examined. Moreover, because many different clinical
and experimental settings have been utilized, no general
conclusion has been reached [7]. Nonetheless, recent data
strongly support the existence of protective Abs against
pathogenic fungi [8–10].
In a previous study, we showed that antigens secreted
by S. schenckii induce a specific humoral response in
infected animals, mainly against the 70 kDa molecule,
indicating the possible participation of specific antibodies
against this molecule in the control of infection [11]. Our
group produced an IgG1 mAb (monoclonal antibody)
against a 70-kDa glycoprotein of S. schenckii. Our results
showed a significant reduction in the number of colony
forming unit (CFU) in the organs of mice when the mAb
was injected before and during S. schenckii infection. Simi-
lar results were observed when T cell-deficient mice were
used. Moreover, in a second treatment schedule, the mAb
was injected after infection was established, and we
observed a significant reduction in CFU [12]. However,
the mechanism associated with the protection was unclear.
The goal of the current study was to determine
whether opsonization of S. schenckii affects the ability of
macrophages to clear this organism and ⁄ or stimulates
cytokine production.
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Abstract
Sporotrichosis is a chronic granulomatous mycosis caused by the dimorphic fun-
gus Sporothrix schenckii. The immunological mechanisms involved in the preven-
tion and control of sporotrichosis suggest that cell-mediated immunity plays an
important role in protecting the host against S. schenckii. Nonetheless, recent data
strongly support the existence of protective Abs against this pathogenic fungus.
In a previous study, we showed that passive Ab therapy led to a significant reduc-
tion in the number of colony forming unit in the organs of mice when the MAb
was injected before and during S. schenckii infection. The ability of opsonization
to enhance macrophage damage to S. schenckii and subsequent cytokine produc-
tion was investigated in this work. Here we show that the fungicidal characteris-
tics of macrophages are increased when the fungus is phagocytosed in the
presence of inactivated serum from mice infected with S. schenckii or mAb anti-
gp70. Additionally, we show an increase in the levels of pro-inflammatory cyto-
kines such as TNF-a and IL-1b. This study provides additional support for the
importance of antibodies in protecting against S. schenckii and concludes that
opsonization is an important process to increase TNF-a production and fungus
killing by macrophages in experimental sporotrichosis.
B A S I C I M M U N O L O G Y doi: 10.1111/j.1365-3083.2011.02636.x
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Materials and methods
Fungal strains. Sporothrix schenckii strain M-64, previ-
ously isolated from a human case of sporotrichosis, was
obtained from the Department of Dermatology of the
Medical School, University of Sao Paulo. Yeast forms of
S. schenckii were grown (3 days, 37 C) in brain-heart
infusion agar (Oxoid, Hampshire, England).
Animals. Female BALB ⁄ c mice, 8–12 weeks old, pro-
vided by the animal facilities of the University of Sao
Paulo (Sa˜o Paulo, SP, Brazil) were used throughout this
study. The local Animal Care and Use Committee
approved the experimental protocols.
Animal infection. Groups of six BALB ⁄ c mice were
infected intraperitoneally with 5 · 106 yeast forms of
S. schenckii suspended in PBS (2.65 g Na2HPO4, 0.35 g
NaH2PO4.H2O and 8.18 g NaCl in 1 l of distilled
water). Blood samples were collected from individual
mice at 14 days after infection, and the serum was inacti-
vated and stored at )20 C until use. As negative control
the mice were infected with only PBS.
Phagocytosis assay. For phagocytic assays, J774.16 cells
were grown in RPMI 1640 (Sigma-Aldrich, St. Louis,
MO, USA) containing 10% FBS (R10), plated on a 24-
well tissue culture plate containing round glass cover
slips and incubated overnight at 37 C in a 5% CO2
atmosphere. The adherent monolayers were co-cultured
with S. schenckii yeast cells. Before the co-culture, yeast
cells were incubated (1 h, 37 C) with heat-inactivated
serum (56 C, 15 min) diluted at 1:50, 1:100, 1:200 or
1:400 in PBS or mAb P6E7 (50 lg ⁄ml) with agitation.
After being washed to remove unbound antibody, macro-
phages were challenged by 24 h with S. schenckii yeast
cells (parasite-to-cell ratio, 3:1). The slides were stained
with Giemsa (Instant Prov Kit; Newprov, Curitiba, Pa-
rana´, Brazil), and the phagocytosis index (PI) was calcu-
lated. An average of 200 macrophages were counted to
determine the PI, calculated as the per cent of phagocytic
cells multiplied by the mean number of internalized par-
ticles [13]. Phagocytosis was confirmed by transmission
electron microscopy, which showed the internalization of
yeast cells by macrophages. The antifungal efficacy of the
J774.16 cells was determined by counting the CFU of
S. schenckii after co-culturing yeasts and macrophages.
Briefly, macrophages were mixed with yeast cells previ-
ously opsonized as described above, and the mixtures
were incubated for 24 or 72 h at 37 C. The contents of
each well were then removed (stored at )80 C for cyto-
kine measurement), and the cells were lysed by the addi-
tion of 200 ll of sterile water and incubated for 15 min.
Supernatants and lysates were pooled and centrifuged,
while the pellet was resuspended in 200 ll of PBS and
then diluted 1:20 in PBS. Five hundred microlitres of
this suspension was plated in Sabouraud dextrose agar.
The number of colonies per plate was counted after
10 days of incubation at 30 C. Controls were performed
using fungi alone or fungi incubated with serum from
non-infected animals. As control of mAb P6E7 was used
an irrelevant monoclonal antibody (MAb anti-carcinoem-
bryonic antigen-CEA 1.H2, IgG1, j light chain). Con-
tamination of the cultures with lipopolysaccharide (LPS)
was monitored using the Limulus amebocyte lysate test
(Endosafe LAL; Charles River, Charleston, SC, USA).
Maximal concentration of LPS detected in the cultures
was always <0.2 ng LPS ⁄ml.
Cytokine measurements. The levels of cytokines in the
supernatants of macrophage cultures were determined by
sandwich enzyme-linked immunosorbent assay (ELISA)
kits according to the manufacturer’s instructions. Macro-
phages were incubated with yeast as described, and after
24 h, the supernatants were harvested and stored at
)70 C for cytokine quantification. Cytokines were quanti-
fied in the supernatants by ELISA (Pharmingen, San Diego,
CA, USA) according to the manufacturer’s instructions.
Cytokine activity was determined using standard curves
with serial dilutions of mouse recombinant cytokines.
Transmission electron microscopy. The phagocytosis assay
was performed as described above. After being cultured,
the macrophages were collected with a cell scraper and were
fixed in osmium tetroxide 1% in cacodylate buffer 0.1 M
(Electron Microscopy Sciences, Hatfield, PA, USA) for
30 min. Dehydration was achieved using various percent-
ages of ethyl alcohol (MERCK, Whitehouse, NJ, USA).
Propylene oxide (Electron Microscopy Sciences) was used as
a solvent for the gradual addition of Araldite resin. After
embedding, samples were maintained in a vacuum for 4 h
and polymerized at 56 C for 48 h. Embedded specimens
were cut (model 702501, Reichert Ultracut; Leica, Solms,
Germany) with glass knives (Reichert-Jung knifemaker
type 705202). Sections 90–95-nm thick were placed onto
300 mesh copper or nickel grids and stained with a 2%
aqueous solution of uranyl acetate (Electron Microscopy
Sciences) for 8 min. These preparations were subsequently
stained with lead citrate in distilled water (Electron
Microscopy Sciences) for 4 min. The grids were examined
and cells photographed in a JEM 1200 EX II electron
microscope (JEOL Ltd., Tokyo, Japan).
Statistical analysis. Statistical comparisons were made
by analysis of variance (ANOVA) and by the Tukey-Kra-
mer post-test. All values are reported as the mean ± stan-
dard error of the means.
Results
Phagocytosis of yeast form of S. schenckii opsonized with
inactivated serum
In this work, we first investigated whether macrophages
would internalize opsonized S. schenckii. For this purpose,
we determined the phagocytic index of macrophages
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co-cultured with S. schenckii previously incubated with
serum. We found that the phagocytosis of S. schenckii by
macrophages in the presence of serum from infected mice
was higher than serum from non-infected mice (control).
A significant increase in phagocytosis was observed in the
presence of serum diluted at 1:50, 1:100 and 1:200
(Fig. 1A). Electronic microscopy was used to demonstrate
the uptake of opsonized yeast (Fig. 1B).
Sporothrix schenckii viability test
We were interested in determining the persistence of
S. schenckii after its uptake by the macrophages. There-
fore, we analysed the fungicidal capacity of the macro-
phages and compared the opsonized yeast with normal
(control) or immune heat serum. In this experiment, we
used serum diluted at 1:200, as dilutions at 1:50 or
1:100 resulted in similar results as those observed above.
A significant decrease in the number of viable yeast cells
after 72 h of incubation was observed in yeast opsonized
with serum (Fig. 2).
Cytokine production
The next step was to determine the cytokine production
by infected macrophages. We found that phagocytosis of
yeast opsonized with serum induced an increase in the
levels of TNF-a, IL-1b, IL-6 and IL-10 compared to
non-opsonized yeast or opsonized with normal serum
(Fig. 3). Similar results were observed when the yeasts
were opsonized with mAb P6E7 (Fig. 4).
Viability of S. schenckii yeast opsonized with mAb P6E7
To verify whether mAb P6E7 against gp70 from S. sche-
nckii could regulate the killing as observed above, we
performed a CFU assay. We observed that yeast opson-
ized with mAb induced an increase in the death of S. sche-
nckii after 72 h of interaction (Fig. 5).
Discussion
The protective role of antibodies against some fungi, such
as Cryptococcus neoformans, is well established [14]. An
important mechanism of protection mediated by antibod-
ies is the opsonization of the microorganism by the Fc
gamma receptor (FccR) [15]. FccR mediates several mac-
rophage functions, including stimulating cytokine secre-
tion, activating respiratory burst, phagocytosis and
antibody-dependent cellular cytotoxicity [16, 17]. Phago-
cytes that bind bacteria via FccR demonstrate increases
in oxidative burst and cytokine production [18, 19]. In
BA
Figure 1 Effect of Ig opsonization on internalization of Sporothrix schenckii by macrophages. (A) Macrophages were incubated for 24 h with yeast (fun-
gus-to-cell ratio, 3:1) which was pretreated with inactivated normal serum (control) or inactivated serum from S. schenckii infected mice (1:50, 1:100,
1:200 or 1:400). Cells were subsequently stained with Giemsa and internalized fungal cells were visualized by light microscopy to determine the
Phagocytosis Index. (B) Phagocytosis for 24 h was confirmed by electron microscopy. Arrows indicate internalized yeast. *P < 0.05 when compared
with the control (macrophages cultivated with S. schenckii previously incubated with 1:200 of inactivated normal mouse serum). The values represent
the mean and the SD obtained from three different experiments.
Figure 2 Fungal viability after phagocytosis. Numbers represent the
recovery of fungal colony forming units (CFU) after 24 and 72 h of the
phagocytosis assay at ratio of 3:1 (fungus ⁄macrophages). *P < 0.05
when compared with a 24-h CFU count. *P < 0.05 when compared
with the control (macrophages cultivated with Sporothrix schenckii previ-
ously incubated with 1:200 of inactivated normal mouse serum). The
values represent the mean and the SD obtained from three different
experiments.
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contrast, neither complement-receptor-mediated nor man-
nose-receptor-mediated recognition promotes these
responses, and these pathways may suppress cytokine pro-
duction [20].
The binding of antibody-opsonized organisms by
phagocytes causes crosslinking of phagocyte receptors for
IgG (FccR), resulting in a complex array of intracellular
signals [21].
The ability of antibody opsonization to enhance
macrophage damage to S. schenckii, and the subsequent
cytokine production, has not been analysed. In the
present study, we have shown that the fungicidal abil-
ity of macrophages is increased when the fungus is
phagocytosed in presence of immune-inactivated serum
or mAb P6E7. However, we observed that macrophages
need, at least, 72 h to efficiently kill the yeast. This
mechanism was more evident when the yeast was ops-
onized with mAb. Maybe the activation of macrophages
by mAb P6E7-opsonized yeast is late when compared
with immune serum-opsonized yeast. This result could
indicate that other factors in the immune serum, apart
from anti-gp70, could participate in macrophages acti-
vation. It is well documented that the activating FccR
plays an important role in activating the production of
pro-inflammatory components. Stimulation of macro-
phages via FccR induces TNF-a secretion. Wijngaarden
et al. [22] showed that treatment of rheumatoid arthri-
tis patients with anti-TNF-a induced a down-regulation
of the activating FccR on monocytes. Pro-inflammatory
cytokines were analysed in our study, and our results
showed a high production of TNF-a and IL-1b when
the fungus was opsonized by serum or mAb P6E7.
The production of the anti-inflammatory cytokine IL-
10 by macrophages was lower when compared with
TNF-a or IL-1b. The production of TNF-a and IL-1b
by macrophages incubated with mAb P6E7-opsonized
yeast was lower than immune serum. TNF-a is a mul-
tifunctional cytokine that plays an important role in
inflammatory responses. Some studies have shown that
TNF-a is an important anti-inflammatory cytokine
involved in the control of sporotrichosis [23, 24]. Gott-
lieb et al. [25] reported a case of disseminated sporotri-
chosis in a patient treated with TNF-a antagonists,
presumably for inflammatory arthritis. This case illus-
trates the importance of TNF-a in the control of
sporotrichosis. It is tempting to speculate that Ab-
mediated phagocytosis may be essential to macrophage
killing, the production of TNF-a and consequently, the
control of sporotrichosis.
Characterizing the mechanism of interactions during
Ab-mediated phagocytosis is important for understanding
the role of Ab generated during the host immune
response and assessing the mechanism of action of passive
Ab therapy, by which treatment with specific mAbs can
improve disease.
Figure 4 Influence of Mab P6E7 on the release of TNF-a, IL-10, IL-
12, IL-1b and IL-6 by macrophages. After 24 h, the supernatants were
harvested and TNF-a, IL-10, IL-12, IL-1b and IL-6 were quantified by
ELISA. *P < 0.05 when compared with the control (macrophages culti-
vated with Sporothrix schenckii previously incubated with irrelevant
Mab). As control the macrophages were incubated with only mAb P6E7
(50 lg ⁄ml). The values represent the mean and the SD obtained from
three different experiments.
Figure 5 Fungal viability after phagocytosis in the presence of Mab
P6E7. The numbers represent the recovery of fungal colony forming
units (CFU) after 24 and 72 h of the phagocytosis assay at ratio of 3:1
(fungus ⁄macrophages). *, P < 0.05 when compared with a 24-h CFU
count. *P < 0.05 when compared with the control (macrophages culti-
vated with Sporothrix schenckii previously incubated with irrelevant
Mab). The values represent the mean and the SD obtained from three
different experiments.
Figure 3 Influence of opsonization with serum from infected mice on
the release of TNF-a, IL-10, IL-12, IL-1b and IL-6 by macrophages.
After 24 h, the supernatants were harvested and TNF-a, IL-10, IL-12,
IL-1b and IL-6 were quantified by ELISA. *P < 0.05 when compared
with the control (macrophages cultivated with Sporothrix schenckii previ-
ously incubated with 1:200 of inactivated normal mouse serum or only
yeast). The values represent the mean and the SD obtained from three
different experiments.
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